60 Participants Needed

Exercise Therapy for Parkinson's Disease

Recruiting at 1 trial location
MR
Overseen ByMarc Roig, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: McGill University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how two exercise types—cardiovascular training (such as running) and resistance training (such as weight lifting)—affect sleep and overall well-being in people with Parkinson's disease. Researchers aim to determine if improved sleep from these exercises also enhances brain health and quality of life. Participants will engage in one type of exercise for 12 weeks, twice a week, with evaluations conducted before and after the program. This trial suits individuals with mild to moderate Parkinson's who experience sleep difficulties and maintain a stable medication routine. As an unphased trial, it offers a unique opportunity to contribute to understanding how exercise can improve life quality for those with Parkinson's.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but it requires that you have been on a stable dosage of medication for the past month.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that both cardiovascular and resistance exercises are generally safe for people with Parkinson's disease (PD). Aerobic exercises, including cardiovascular workouts, can improve balance, walking, and motor skills in individuals with PD. They also help lower the risk of heart disease and can increase life expectancy. Some research suggests that high-intensity aerobic exercise might protect brain cells that produce dopamine, which is important for movement.

Resistance training is also beneficial. Studies indicate it increases muscle strength and aids mobility. It can improve quality of life and help with issues like "freezing of gait," when someone feels stuck and unable to move.

Both types of exercise have been extensively studied and are well-tolerated. No major safety concerns have been reported for either type in people with Parkinson's disease. Participants usually manage these exercises well, making them a safe option for those considering joining a trial.12345

Why are researchers excited about this trial?

Researchers are excited about exploring exercise therapy for Parkinson's Disease because it taps into the body's natural ability to improve its own function without medication. Unlike standard treatments that primarily rely on medication to manage symptoms, cardiovascular and resistance training focus on enhancing physical fitness, which could lead to improved mobility and strength. Cardiovascular training ramps up gradually to a vigorous intensity, potentially boosting heart health and endurance, while resistance training strengthens muscles through a systematic increase in intensity. These methods offer a non-invasive, holistic approach that might complement existing treatments and improve quality of life for patients.

What evidence suggests that this trial's treatments could be effective for Parkinson's disease?

This trial will compare two types of exercise therapy for Parkinson's disease: cardiovascular training and resistance training. Research has shown that aerobic exercise, such as cardiovascular training, can improve heart health and reduce the risk of heart disease in people with Parkinson's. Regular aerobic exercise may also slow the progression of Parkinson's and protect dopamine-producing brain cells, which are often lost in the disease. Meanwhile, resistance training has significantly increased muscle strength, by 15% to 83.2%, in people with Parkinson's. This type of exercise can also enhance coordination and balance, making everyday movements easier. Both exercise types improve movement-related symptoms in Parkinson's, making them promising therapy options.23678

Are You a Good Fit for This Trial?

This trial is for people with mild to moderate Parkinson's Disease who have poor sleep quality but are on stable medication. They should not be in other drug/exercise trials, have severe untreated sleep apnea, dementia or conditions that prevent exercise. A score >18 on PDSS-2 and <21 on MoCA excludes them.

Inclusion Criteria

My medication dose has been the same for the last month.
My Parkinson's Disease is in the early to middle stages.
You have been diagnosed with significant sleep problems, with a score higher than 18 on a sleep quality test called the PDSS-2.

Exclusion Criteria

You have a Beck Depression Inventory (BDI version 2) score higher than 4.
You have been regularly doing structured exercise at least twice a week for the past two months before joining the study.
I have a health condition that makes it hard for me to exercise.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants perform either cardiovascular training or resistance training for 12 weeks, at least two times per week

12 weeks
24 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Cardiovascular Training
  • Resistance Training
Trial Overview The study tests how cardiovascular (CT) and resistance training (RT) affect sleep quality in Parkinson's patients over 12 weeks of training at least twice a week. It also looks at whether better sleep improves brain function and life quality.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Resistance trainingExperimental Treatment1 Intervention
Group II: Cardiovascular trainingExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

McGill University

Lead Sponsor

Trials
421
Recruited
1,017,000+

Jewish Rehabilitation Hospital

Collaborator

Trials
7
Recruited
810+

Published Research Related to This Trial

Resistance training (RT) and endurance training (ET) are safe and feasible exercise modalities for people with Parkinson's disease, showing significant benefits in muscle strength, functional capacity, and quality of life based on a review of 33 new randomized controlled trials.
RT demonstrated a strong positive impact on muscle strength (SMD = 0.83) and functional capacity, while ET improved cardiorespiratory fitness (SMD = 0.27) and also showed potential benefits for functional outcomes, indicating that both types of exercise can be effective adjunct therapies for managing Parkinson's disease.
Parkinson's disease and intensive exercise therapy - An updated systematic review and meta-analysis.Gamborg, M., Hvid, LG., Dalgas, U., et al.[2022]
Resistance Training (RT) is shown to significantly improve muscle strength in individuals with Parkinson's Disease, with a moderate effect size based on a meta-analysis of 15 randomized controlled trials.
All three exercise modalities—Resistance Training, Endurance Training, and Other Intensive Training Modalities—are safe and feasible, potentially benefiting balance, walking performance, and quality of life in Parkinson's Disease, with no reported deterioration in outcomes.
Parkinson's disease and intensive exercise therapy--a systematic review and meta-analysis of randomized controlled trials.Uhrbrand, A., Stenager, E., Pedersen, MS., et al.[2018]
Resistance training (RT) significantly improves knee extension, knee flexion, and leg press strength in people with Parkinson's disease compared to control groups, based on a systematic review of nine studies.
Combining RT with other forms of exercise, such as aerobic or balance training, leads to even greater improvements in strength, although RT alone may not always outperform other exercise types for certain muscle groups.
Effects of Resistance Training on Measures of Muscular Strength in People with Parkinson's Disease: A Systematic Review and Meta-Analysis.Roeder, L., Costello, JT., Smith, SS., et al.[2018]

Citations

Cardiopulmonary Function and Aerobic Exercise in Parkinson'sIn general, aerobic exercise was found to have positive effects on cardiac function for people with Parkinson's, but there is a lack of studies on the effects ...
Current Perspectives on Aerobic Exercise in People with ...Aerobic exercise has generic health benefits for people with PD, including a reduced incidence of cardiovascular disease, a lower mortality, and an improved ...
Effectiveness of aerobic and resistance training on the ...Aerobic and resistance training are common complementary therapies to improve motor symptoms in people with Parkinson's disease (PD).
Are physical activity levels, cardiorespiratory fitness and ...Increased physical activity (PA) may slow Parkinson's disease (PD) progression. Associations between markers of PA and PD severity could ...
High-intensity Exercise May Reverse Neurodegeneration in ...Six months of high-intensity aerobic exercise preserves the dopamine-producing neurons in the brain, a small pilot study finds.
A systematic review and meta-analysis on effects of aerobic ...Aerobic exercise had beneficial effects in improving balance, gait (velocity and stride/step length), and motor function in PD patients.
Comparison of the Effect of Aerobic and Resistance ...The results showed that both types of aerobic and resistance training can reduce the risk factors of cardiovascular disease in women with PD.
Effects of Aerobic Exercise in Parkinson's DiseaseIn the third year, all participants were assigned to the continuous arm after preliminary analyses of prior data raised safety concerns about interval training.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security